GLP-1R agonists have demonstrated interesting results in individuals with ASP (with or without OSA), while results from future RCTs and post hoc analyses from other published RCTs are anticipated (Table I)
Tirzepatide carries a Boxed Warning regarding thyroid C-cell tumors observed in rodent studies and is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
It works faster than most people expect, with symptom relief such as reduced discharge or discomfort typically beginning within the first 3 to 5 days
Zhao R, Zarabi SF, Nii T, Halgas O, Jitkova Y, Ruvolo V, Heese L, Nishida Y, Borthakur G, Kojima K, Stogniew M, Oster W, Pai E, Davis RE, Kantarjian H, Schimmer AD, Andreeff M , Ishizawa J
The importance of B12 in maintaining overall health cannot be reiterated enough
How much does NexLife tirzepatide cost